Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine David J. IrwinNigel J. CairnsJohn Q. Trojanowski Review 31 December 2014 Pages: 469 - 491
One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition Brett FriedlerJoshua CrapserLouise McCullough Review 24 December 2014 Pages: 493 - 509
Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease Lucie A. G. van LeeuwenJeroen J. M. Hoozemans Review Open access 25 January 2015 Pages: 511 - 525
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease Alan King Lun LiuRaymond Chuen-Chung ChangSteve M. Gentleman Review Open access 30 January 2015 Pages: 527 - 540
Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease Csaba ÁdoriLaura GlückTomas Hökfelt Original Paper 13 February 2015 Pages: 541 - 563
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease Maike Hartlage-RübsamenAlexander WaniekSteffen Roßner Original Paper Open access 11 February 2015 Pages: 565 - 583
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas Adriana OlarKhalida M. WaniKenneth D. Aldape Original Paper 21 February 2015 Pages: 585 - 596
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment Hinke F. van ThuijlTali MazorJoseph F. Costello Original Paper 28 February 2015 Pages: 597 - 607
High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN) Fausto J. RodriguezMatthew J. SchniederjanArie Perry Correspondence 27 February 2015 Pages: 609 - 610